COMMUNIQUÉS West-GlobeNewswire

ALK appoints Tina Abild Olesen as Executive Vice President for Corporate, Portfolio and Product Strategy
21/09/2026
ALK today announced the appointment of Tina Abild Olesen as Executive Vice President for Corporate, Portfolio and Product Strategy (CPPS), effective 1 October 2026. Tina succeeds Jacob Glenting, who headed CPPS before [...]
Novo's CagriSema delivers superior weight loss versus tirzepatide in REIMAGINE 5 trial
21/09/2026
CagriSema 1.0 mg/1.0 mg achieved superior weight loss of 12.4%* versus tirzepatide 5 mg of 9.1%* and non-inferior HbA 1c reduction at week 60 in adults with type 2 diabetes in REIMAGINE 5. CagriSema 1.0 mg/1.0 mg [...]
Underarm Pad Surface Area and Handle Angle: The Measurements Behind Crutch Comfort
21/09/2026
Drive Medical builds the MD by Drive Air-Crutch handle angle and grip size around load calculations run at the handgrip by Max Younger, who designed the crutch and now leads the line. The Airgonomic™ underarm cushion [...]
Tiziana Announces Last Patient Completes Last Visit in Phase 2a INFORM-MS Trial of Intranasal Foralumab
21/09/2026
BOSTON, Sept. 21, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA ) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development [...]
Axsome Therapeutics Announces Results of the Shared Goals Survey of Caregivers of Patients with Alzheimer’s Disease Agitation Presented at Psych Congress 2026 in Connection with World Alzheimer’s Day
21/09/2026
The Shared Goals: Navigating Alzheimer’s Agitation survey finds that Alzheimer’s disease agitation is often only recognized after daily life is significantly disrupted Ninety-seven percent of care partners reported that [...]
Seer Announces CFO Transition
21/09/2026
REDWOOD CITY, Calif., Sept. 21, 2026 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER) (“Seer” or the “Company”), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that David Horn, the [...]
Vironexis Announces Complete and Durable Responses in Relapsed/Refractory ALL Patients Treated with VNX-101
21/09/2026
In the ongoing SENTRY-CD19 trial, all three anti-AAV antibody-naïve patients with relapsed/refractory acute lymphoblastic leukemia (ALL) have achieved MRD-negative complete responses following a single administration of [...]
Beacon Therapeutics Reports Positive Topline Data from the Pivotal VISTA Trial of Laru-zova for the Treatment of X-linked Retinitis Pigmentosa (XLRP)
21/09/2026
VISTA met its FDA-endorsed primary endpoint, demonstrating statistically significant low luminance visual acuity (LLVA) responder rates at Month 12 compared to the untreated control group A statistically significant [...]
Dr. Maximilian Doebler appointed Chief Executive Officer of HMNC Brain Health as Company moves into next phase of global growth
21/09/2026
HMNC recently closed a $50 million Series B financing and a European commercialization partnership with MEDICE for its Ketabon program Doebler has helped shape HMNC's development since 2019, most recently as Managing [...]
InflaRx to Host Virtual Capital Markets Day
21/09/2026
Event to be hosted on November 3, 2026 at 8:00 AM EST Featured speakers will include Peter A. Merkel, MD, MPH and Prof. Dr. Jörg Köhl Jena, Germany, Sept. 21, 2026 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a [...]
Medicus Pharma Announces Exclusive Development Focus for SkinJect® in Gorlin Syndrome Following Commercial, Clinical and Regulatory Assessment
21/09/2026
Decision advances Company’s previously announced capital-efficient development strategy by concentrating resources on FDA-authorized, SKNJCT-005, NDA-enabling, Registrational Phase 2b Study in Gorlin syndrome patients [...]
Helus Pharma Presents New Analyses on HLP003 in Major Depressive Disorder at Psych Congress 2026
21/09/2026
Poster presentations further characterize clinical profile of HLP003 and Phase 3 PARADIGM program evaluating HLP003 as a potential adjunctive treatment for major depressive disorder (“MDD”) NEW YORK and TORONTO, Sept. [...]
Beacon Therapeutics Reports Positive Topline Data from the Pivotal VISTA Trial of Laru-zova for the Treatment of X-linked Retinitis Pigmentosa (XLRP)
21/09/2026
VISTA met its FDA-endorsed primary endpoint, demonstrating statistically significant low luminance visual acuity (LLVA) responder rates at Month 12 compared to the untreated control group A statistically significant [...]
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
21/09/2026
COPENHAGEN, Denmark, September 21, 2026 – Bavarian Nordic A/S (OMX: BAVA) announces transactions under the share buy-back program launched on September 1, 2026, under which the Company will repurchase shares for an [...]
Highlights to be presented at Novo’s Capital Markets Day 2026
21/09/2026
Bagsværd, Denmark, 21 September 2026 – Novo Nordisk is today hosting a Capital Markets Day (CMD) in London, where the company is providing an update to its Corporate strategy and strategic ambitions for 2030 1 . During [...]
Telix and ITM Join Forces to Create a Radiopharmaceutical Powerhouse
21/09/2026
Transformational merger reinforces Telix’s long-term growth strategy as a vertically integrated radiopharmaceutical company with enhanced capabilities across development, isotope production and global manufacturing, [...]
Cue Biopharma Announces Positive Topline Results from CUE-221 Phase 2 Study in Chronic Spontaneous Urticaria
20/09/2026
Results support potential for differentiated clinical impact for patients suffering from chronic hives and advancement to Phase 2b/3 registration enabling study Primary endpoint and the key secondary endpoint were met [...]
SodaPeak Launch 2026: Effective Formula For Men Health Supports Men's Virility and vitality. Read Soda Peak Gummies Supplement Facts & Ingredients Highlights.
20/09/2026
Soda Peak Gummies introduces a natural vitality formula for men, featuring SodaPeak with selected botanical ingredients, supplement facts, and a multi-ingredient blend designed for everyday men’s wellness and vitality [...]
NorahLux Launches Red Light Therapy Research Hub With Access to 10,000+ Photobiomodulation Studies
20/09/2026
Interactive research explorer helps users search scientific literature by condition, study type, light source and other criteria DEURNE, Netherlands, Sept. 19, 2026 (GLOBE NEWSWIRE) -- NorahLux has launched the Red [...]

Pages